Similar articles

• Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.

  Coleman RE. Coleman RE. Oncology (Williston Park). 1991 Aug;5(8):55-60; discussion 60-2, 65. Oncology (Williston Park). 1991. PMID: 1834153
• Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.

  Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S. Paterson AH, et al. Can J Oncol. 1995 Dec;5 Suppl 1:54-7. Can J Oncol. 1995. PMID: 8853526
• Use of bisphosphonates in cancer patients.

  Body JJ, Coleman RE, Piccart M. Body JJ, et al. Cancer Treat Rev. 1996 Jul;22(4):265-87. doi: 10.1016/s0305-7372(96)90020-1. Cancer Treat Rev. 1996. PMID: 9025784 Review. No abstract available.
• Bisphosphonates: expanded roles in the treatment of patients with cancer.

  Viale PH, Sanchez Yamamoto D. Viale PH, et al. Clin J Oncol Nurs. 2003 Jul-Aug;7(4):393-401. doi: 10.1188/03.CJON.393-401. Clin J Oncol Nurs. 2003. PMID: 12929272
• Aredia: the once-monthly infusion for the treatment of bone metastases.

  Lipton A. Lipton A. Curr Opin Oncol. 1998 Aug;10 Suppl 1:S1-5. Curr Opin Oncol. 1998. PMID: 9801852 Review.